Mark Berger

Chief Tech/Sci/R&D Officer at GENPREX, INC.

Net worth: 5 805 $ as of 2026-05-30

71 year

Health Technology

Consumer Services

Profile

Mark S.
Berger is currently Chief Medical Officer at Genprex, Inc. since 2021.
Former positions include Senior Director-Oncology Clinical Development at Wyeth Pharmaceuticals LLC; Group Director-Clinical Oncology at GSK Plc from 2002 to 2007; Principal at the University of Pennsylvania; Vice President-Clinical Development at Gemin X Pharmaceuticals US, Inc. from 2007 to 2011; Chief Medical Officer at Deciphera Pharmaceuticals LLC from 2011 to 2013; Senior Vice President-Clinical Research at Kadmon Corp.
LLC from 2013 to 2017; and Chief Medical Officer at Actinium Pharmaceuticals, Inc. from 2017 to 2021.
Education includes undergraduate studies at Wesleyan University and a doctorate from The University of Virginia School of Medicine.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
GENPREX INC 0.07%	2026-04-14	7,442 ( 0.07% )	5 805 $	2026-05-30

Mark Berger active positions

Companies	Position	Start
GENPREX, INC.	Chief Tech/Sci/R&D Officer	2021-09-26

All active positions of Mark Berger

Former positions of Mark Berger

Companies	Position	End
ACTINIUM PHARMACEUTICALS, INC.	Chief Tech/Sci/R&D Officer	2021-09-23
Kadmon Corp. LLC Kadmon Corp. LLC Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products	Chief Tech/Sci/R&D Officer	2016-12-31
Deciphera Pharmaceuticals LLC Deciphera Pharmaceuticals LLC BiotechnologyHealth Technology Discovers and develops pharmaceutical preparations	Chief Tech/Sci/R&D Officer	2013-08-31
Gemin X Pharmaceuticals US, Inc. Gemin X Pharmaceuticals US, Inc. BiotechnologyHealth Technology Develops cancer therapeutic products	Corporate Officer/Principal	2011-05-31
GSK PLC	Corporate Officer/Principal	2007-01-31

See the detail of Mark Berger's experience

Training of Mark Berger

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Mark Berger's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	10
Wyeth Pharmaceuticals LLC Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets infant pharmaceutical products	Health Technology
Genprex, Inc. Genprex, Inc. Pharmaceuticals: MajorHealth Technology Develops molecular therapies for cancer treatment	Health Technology
GSK Plc GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products	Health Technology
University of Pennsylvania University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Wesleyan University Wesleyan University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Gemin X Pharmaceuticals US, Inc. Gemin X Pharmaceuticals US, Inc. BiotechnologyHealth Technology Develops cancer therapeutic products	Health Technology
Deciphera Pharmaceuticals LLC Deciphera Pharmaceuticals LLC BiotechnologyHealth Technology Discovers and develops pharmaceutical preparations	Health Technology
Kadmon Corp. LLC Kadmon Corp. LLC Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products	Health Technology
Actinium Pharmaceuticals, Inc. Actinium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company developing targeted payload immunotherapeutic for the treatment of advanced cancers	Health Technology
The University of Virginia School of Medicine The University of Virginia School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services